Corey Davis
Stock Analyst at HC Wainwright & Co.
(2.94)
# 1,437
Out of 5,116 analysts
17
Total ratings
75%
Success rate
25.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corey Davis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Reiterates: Neutral | $480 → $390 | $37.33 | +944.74% | 5 | May 12, 2020 | |
| SCYX SCYNEXIS | Assumes: Buy | $50 | $0.71 | +6,932.35% | 3 | May 7, 2018 | |
| VTVT vTv Therapeutics | Downgrades: Neutral | $560 → $40 | $35.98 | +11.17% | 2 | Apr 10, 2018 | |
| LPCN Lipocine | Initiates: Buy | $170 | $9.00 | +1,788.89% | 1 | Mar 29, 2018 | |
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $20 | $7.54 | +165.25% | 2 | Jan 19, 2018 | |
| PCRX Pacira BioSciences | Initiates: Buy | $50 | $20.54 | +143.43% | 3 | Jan 19, 2018 | |
| JAZZ Jazz Pharmaceuticals | Initiates: Neutral | $144 | $164.49 | -12.46% | 1 | Aug 25, 2017 |
Nektar Therapeutics
May 12, 2020
Reiterates: Neutral
Price Target: $480 → $390
Current: $37.33
Upside: +944.74%
SCYNEXIS
May 7, 2018
Assumes: Buy
Price Target: $50
Current: $0.71
Upside: +6,932.35%
vTv Therapeutics
Apr 10, 2018
Downgrades: Neutral
Price Target: $560 → $40
Current: $35.98
Upside: +11.17%
Lipocine
Mar 29, 2018
Initiates: Buy
Price Target: $170
Current: $9.00
Upside: +1,788.89%
Vanda Pharmaceuticals
Jan 19, 2018
Initiates: Buy
Price Target: $20
Current: $7.54
Upside: +165.25%
Pacira BioSciences
Jan 19, 2018
Initiates: Buy
Price Target: $50
Current: $20.54
Upside: +143.43%
Jazz Pharmaceuticals
Aug 25, 2017
Initiates: Neutral
Price Target: $144
Current: $164.49
Upside: -12.46%